Multicentre, Phase II Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Adenocarcinoma of the Oesophagogastric Junction and Stomach

Trial Profile

Multicentre, Phase II Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Adenocarcinoma of the Oesophagogastric Junction and Stomach

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Apr 2018

At a glance

  • Drugs Cabazitaxel (Primary)
  • Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
  • Focus Therapeutic Use
  • Acronyms CabaGast
  • Most Recent Events

    • 17 Apr 2018 Status changed from active, no longer recruiting to completed.
    • 01 Mar 2018 Results published in the Journal of Cancer Research and Clinical Oncology.
    • 08 Jan 2018 Planned End Date changed from 1 Jun 2017 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top